During the last few years numerous in vitro and in vivo preclinical studies have demonstrated that dietary LCn-3 PUFA have the potential to exert a preventive and therapeutic role against breast cancer through the negative regulation of the ERK and/or phosphoinositide survival pathways. The gene discussed is MAPK1; the disease is breast cancer.